DK0920329T3 - Stabilisering af interferoner i vandig opløsning med gummiarabicum - Google Patents

Stabilisering af interferoner i vandig opløsning med gummiarabicum

Info

Publication number
DK0920329T3
DK0920329T3 DK97919596T DK97919596T DK0920329T3 DK 0920329 T3 DK0920329 T3 DK 0920329T3 DK 97919596 T DK97919596 T DK 97919596T DK 97919596 T DK97919596 T DK 97919596T DK 0920329 T3 DK0920329 T3 DK 0920329T3
Authority
DK
Denmark
Prior art keywords
interferons
stabilization
aqueous solution
gum arabic
arabic
Prior art date
Application number
DK97919596T
Other languages
Danish (da)
English (en)
Inventor
Peter R Rothschild
Original Assignee
Feronpatent Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Feronpatent Ltd filed Critical Feronpatent Ltd
Application granted granted Critical
Publication of DK0920329T3 publication Critical patent/DK0920329T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97919596T 1996-05-09 1997-05-09 Stabilisering af interferoner i vandig opløsning med gummiarabicum DK0920329T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB9600433 1996-05-09
PCT/IB1997/000531 WO1997041885A1 (fr) 1996-05-09 1997-05-09 Stabilisation des interferons dans une solution aqueuse pour la fabrication de tablettes a administration sublinguale

Publications (1)

Publication Number Publication Date
DK0920329T3 true DK0920329T3 (da) 2003-01-27

Family

ID=11004429

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97919596T DK0920329T3 (da) 1996-05-09 1997-05-09 Stabilisering af interferoner i vandig opløsning med gummiarabicum

Country Status (8)

Country Link
EP (1) EP0920329B1 (fr)
AP (1) AP1168A (fr)
AT (1) ATE224725T1 (fr)
AU (1) AU2401197A (fr)
DE (1) DE69715883T2 (fr)
DK (1) DK0920329T3 (fr)
ES (1) ES2184084T3 (fr)
WO (1) WO1997041885A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0920329B1 (fr) * 1996-05-09 2002-09-25 Feronpatent Limited Stabilisation des interferons dans une solution aqueuse par de la gomme arabique
JP2001526662A (ja) * 1997-05-09 2001-12-18 フェロンパテント リミテッド 舌下投与式タブレットの製造のための水溶液におけるインターフェロンの安定化
US6391296B1 (en) 1997-08-01 2002-05-21 Toray Industries, Inc. Method of stabilizing useful protein and useful protein compositions
FR2836379B1 (fr) * 2002-02-28 2007-06-01 Dit Bon Michel Betend Formes galeniques solides de medicaments homeopathiques, dont les allergenes ou antigenes, en dilutions homeopathiques pour preparation extemporanee pour un seul individu pour administration sublinguale
JP2008501639A (ja) * 2004-04-23 2008-01-24 ノベシン リミテッド タンパク質を安定化、保護及び可溶化させるための方法及びキット
WO2005103067A1 (fr) * 2004-04-23 2005-11-03 Novexin Limited Procedes et kits pour stabiliser, proteger et solubiliser des proteines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH156609A (de) * 1931-01-27 1932-08-15 Chem Pharm Lab Bika V Poehlman Verfahren zur Herstellung eines trockenen, homöopathischen Heilmittels.
EP0123291A2 (fr) * 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Méthode de stabilisation d'interféron
EP0133767B1 (fr) * 1983-08-04 1991-04-03 The Green Cross Corporation Composition de gamma interféron
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
FR2619714B1 (fr) * 1987-09-02 1991-07-12 Medibrevex Nouvelles formes galeniques de theophylline pour administration par voie per- et sublinguale
CA2024046A1 (fr) * 1989-09-28 1991-03-29 Alberto Ferro Interferons stabilises
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
EP0920329B1 (fr) * 1996-05-09 2002-09-25 Feronpatent Limited Stabilisation des interferons dans une solution aqueuse par de la gomme arabique

Also Published As

Publication number Publication date
ES2184084T3 (es) 2003-04-01
EP0920329A1 (fr) 1999-06-09
DE69715883T2 (de) 2003-07-31
WO1997041885A1 (fr) 1997-11-13
ATE224725T1 (de) 2002-10-15
AP1168A (en) 2003-06-30
DE69715883D1 (de) 2002-10-31
EP0920329B1 (fr) 2002-09-25
AU2401197A (en) 1997-11-26
AP9901682A0 (en) 1999-12-31

Similar Documents

Publication Publication Date Title
ATE251130T1 (de) Neue 3-aryl-propionsäurederivate und analoge
NL300379I1 (nl) Bepaalde 5-alkyl-2- arylaminofenylazijnzuren en derivaten daarvan
NO20001983D0 (no) Amidderivater eller salter derav
NO975104D0 (no) Benzotiazol UV absorberingsmidler med forsterket varighet
DE59903356D1 (de) Blasensäule und deren verwendung
DE59812316D1 (de) Neue Insulinderivate mit schnellem Wirkungseintritt
DE69700813D1 (de) Verwendung von stabilen aminofunktionellen latexen in wässrigen tinten
EE200000732A (et) Karnitiini ja glutatiooni sisaldav kompositsioon glutatiooni imendumise suurendamiseks ning selle efektide sünergismiks
DK1017408T3 (da) Anvendelse af tetrahydrolipstatin i behandling af diabetes type II
DK1070093T3 (da) Inhærent lys- og varmestabiliserede polyamider med forbedret vådægthed
DK0903130T3 (da) Forbedringer i forbindelse med ostomiindretninger
DK0920329T3 (da) Stabilisering af interferoner i vandig opløsning med gummiarabicum
NO972741D0 (no) Absorberende gjenstand med forbedret passformsystem
NO985937D0 (no) Dentalt implantatsystem med forbedret stabilitet
NO970103D0 (no) Forbedringer ved eller i forbindelse med fiskeoppdrettsanlegg
DK0941081T3 (da) Ny anvendelse af creatin
BR9508026A (pt) Acetogeninas e derivados bioativos
FI980507A0 (fi) Mer- och/eller extrakapacitetens realisering i basstationtransmission
DK1019042T3 (da) Forbindelser med anti-første-passagevirkning
KR950026541U (ko) 액자 및 집게가 일체로 구성된 거울
FI974544A0 (fi) Anordning i en med manoeverplats foersedd lastkran
ITRM980697A0 (it) Moncone con ammortizzatore da applicare su viti per impiantologia odontoiatrica
FI970497A0 (fi) Arrangemang foer raeddningsvaeg i en byggnad med flera vaoningar
DE9406871U1 (de) Gerüst mit zueinander parallelen Stellrahmen
IT1273868B (it) Perfezionamenti nelle cornici dei telai